Medesis Pharma Sa Stock Revenue
| ALMDP Stock | EUR 0.35 0.01 2.94% |
Medesis Pharma SA fundamentals help investors to digest information that contributes to Medesis Pharma's financial success or failures. It also enables traders to predict the movement of Medesis Stock. The fundamental analysis module provides a way to measure Medesis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medesis Pharma stock.
Medesis |
Medesis Pharma SA Company Revenue Analysis
Medesis Pharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Medesis Pharma Revenue | 95.73 K |
Most of Medesis Pharma's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medesis Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Medesis Pharma SA reported 95.73 K of revenue. This is 100.0% lower than that of the Healthcare sector and 99.99% lower than that of the Biotechnology industry. The revenue for all France stocks is 100.0% higher than that of the company.
Medesis Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medesis Pharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medesis Pharma could also be used in its relative valuation, which is a method of valuing Medesis Pharma by comparing valuation metrics of similar companies.Medesis Pharma is currently under evaluation in revenue category among its peers.
Medesis Fundamentals
| Current Valuation | 8.67 M | |||
| Shares Outstanding | 4.39 M | |||
| Shares Owned By Insiders | 17.28 % | |||
| Price To Book | 74.91 X | |||
| Price To Sales | 189.31 X | |||
| Revenue | 95.73 K | |||
| EBITDA | (3.05 M) | |||
| Net Income | (2.65 M) | |||
| Cash And Equivalents | 2.89 M | |||
| Total Debt | 1.28 M | |||
| Earnings Per Share | (0.74) X | |||
| Target Price | 4.1 | |||
| Market Capitalization | 13.43 M | |||
| Total Asset | 4.33 M | |||
| Z Score | 6.0 | |||
| Net Asset | 4.33 M |
About Medesis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medesis Pharma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medesis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medesis Pharma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.